v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities:    
Net Income $ 24,447 $ 17,115
Provision for Credit Losses 3,375 5,613
Depreciation and Amortization 2,576 2,619
Net gain on equity securities (300) (277)
Loans originated and held-for-sale (14,427) (14,514)
Proceeds from the sale of loans held-for-sale 17,478 11,013
Net gain on the sale of loans (444) (314)
Net loss (gain) on the sale of premises and equipment, other real estate owned and repossessed assets 87 (59)
Contributions to retirement benefit plans (352) (339)
Deferred income tax benefit (2,379) (123)
Settlement of purchased Energy Production Tax Credits (5,920) 0
Shares issued under the Directors’ Stock Plan 241 251
Stock-based compensation expense 551 422
Tax benefit from exercise of stock options 252 111
Net (increase) decrease in Other Assets (216) 1,027
Net increase (decrease) in Other Liabilities 6,069 (2,197)
Net Cash Provided By Operating Activities 31,038 20,348
Cash Flows from Investing Activities:    
Proceeds from maturities, calls, and principal repayments of securities AFS 36,730 68,437
Purchases of securities AFS (43,152) (39,623)
Proceeds from maturities, calls, and principal repayments of securities HTM 23,485 33,932
Purchases of securities HTM (22,019) (6,570)
Net increase in loans (49,182) (42,488)
Proceeds from sales of premises and equipment, OREO and repos 1,357 1,439
Purchases of premises and equipment (5,510) (3,276)
Purchase of FHLB stock (13,979) (204)
Net Cash (Used) Provided By Investing Activities (72,270) 11,647
Cash Flows from Financing Activities:    
Net change in deposits (284,264) 101,400
Finance lease payments (42) (36)
Increase in Borrowings 305,925 0
Net cash collateral received from (paid to) derivative counterparties 1,650 (1,710)
Purchase of treasury stock (483) (8,654)
Stock options exercised, net 810 102
Shares issued under ESPP 153 165
Cash dividends paid (9,912) (9,360)
Net Cash Provided By Financing Activities 13,837 81,907
Net (Decrease) Increase in Cash and Cash Equivalents (27,395) 113,902
Cash and Cash Equivalents at Beginning of Period 214,183 154,546
Cash and Cash Equivalents at End of Period 186,788 268,448
Supplemental Disclosures to Statements of Cash Flow Information:    
Interest on deposits and borrowings 36,413 37,730
Income taxes 9,123 4,207
Transfer of loans to other real estate owned and repossessed assets 1,494 1,431
Total fair value of Commercial Loan Participation transferred to Other Assets $ 0 $ 10,648